Welcome to the Orange Book Blog! We’re a group of patent attorneys who like to write about ongoing events in the world of Hatch-Waxman Litigation, as well as biosimilars and related topics.
Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Orange Book Blog 